Symbicort is not a rescue inhaler. Its FDA label explicitly states it is “not indicated for the relief of acute bronchospasm” and should not replace a fast-acting rescue inhaler. However, the answer gets more nuanced in practice: many doctors now prescribe Symbicort in a specific way that includes using it for quick relief of symptoms, a strategy called SMART therapy. Understanding the difference between these two uses matters for how you manage your asthma day to day.
Why Symbicort Isn’t a Standard Rescue Inhaler
A traditional rescue inhaler contains albuterol, a short-acting medication that opens your airways within seconds to minutes during an asthma attack. Symbicort contains two medications: budesonide (a steroid that reduces inflammation) and formoterol (a long-acting bronchodilator that opens airways). It’s designed as a maintenance inhaler, meaning you take it on a regular schedule to prevent symptoms rather than to stop an attack already in progress.
The FDA’s patient information is direct: “SYMBICORT does not relieve sudden symptoms. Always have a rescue inhaler medicine with you to treat sudden symptoms.” For both asthma and COPD, this is the official position.
What SMART Therapy Changes
Here’s where it gets interesting. Both the Global Initiative for Asthma and the U.S. National Asthma Education and Prevention Program now recommend something called SMART therapy (Single Maintenance and Reliever Therapy). Under this approach, you use the same Symbicort inhaler for your daily maintenance doses and for quick relief when symptoms break through. One inhaler does both jobs.
This works because of formoterol, the bronchodilator in Symbicort. Unlike other long-acting bronchodilators, formoterol starts working quickly. In clinical studies, most patients achieved significant airway opening within about 12 minutes of a dose. That’s slower than albuterol but fast enough to provide meaningful relief during a flare-up. And because every puff also delivers budesonide, each rescue dose adds a small burst of anti-inflammatory medication right when your airways need it most.
The practical result is that when symptoms worsen, you’re automatically getting more inflammation control instead of just temporarily forcing your airways open. This self-adjusting quality is what makes SMART therapy effective.
How SMART Dosing Works
Under SMART therapy, your doctor prescribes a specific low-strength formulation of budesonide-formoterol (160/4.5 micrograms per puff). You take one or two puffs once or twice daily as your regular maintenance dose, depending on your asthma severity. When symptoms flare, you take one additional puff as needed for relief, up to a maximum of 12 total puffs in a single day for anyone 12 or older. Children between 5 and 11 use a lower-strength formulation with a maximum of 8 puffs daily.
This is not the same as grabbing your maintenance inhaler during an emergency on your own. SMART therapy requires your doctor to specifically prescribe Symbicort this way and set your dosing limits. If your prescription says to take two puffs twice daily and nothing more, that’s not a SMART prescription, and you still need a separate rescue inhaler.
Symbicort vs. Albuterol for Rescue
A major 52-week trial called Novel START compared as-needed budesonide-formoterol against as-needed albuterol in 675 adults with mild asthma. The results strongly favored the combination inhaler: patients using budesonide-formoterol had roughly 50% fewer asthma flare-ups compared to the albuterol group. Severe exacerbations (emergency visits, hospitalizations, or courses of oral steroids) were 60% less common.
The reason comes down to inflammation. Albuterol opens your airways but does nothing about the underlying swelling that causes attacks. Every time you reach for budesonide-formoterol instead, you’re treating both the symptom and the cause simultaneously. Over months, that adds up to meaningfully better asthma control.
Important Limitations
SMART therapy has only been studied and validated with two specific drug combinations: budesonide-formoterol (Symbicort) and beclometasone-formoterol. Other combination inhalers, like fluticasone-salmeterol (Advair), do not work this way because salmeterol takes much longer to kick in. You cannot substitute a different maintenance inhaler and assume it will provide quick relief.
Most clinical trials of SMART therapy enrolled adults and adolescents aged 12 and older, so the evidence base is strongest for that age group. Side effects from extra doses can include shaky hands and a faster heart rate, which is why the daily puff limits exist. Once your breathing returns to normal after using extra puffs, you should stop taking additional doses.
For COPD specifically, Symbicort remains a maintenance-only medication. The SMART approach applies to asthma management, and COPD patients should continue using their prescribed short-acting rescue inhaler for acute symptoms.
What This Means for You
If your doctor has not specifically prescribed Symbicort under a SMART protocol, you need a separate rescue inhaler and should carry it with you. Do not use your regular Symbicort for sudden breathing problems unless your prescription explicitly includes as-needed rescue puffs with a defined daily maximum.
If you’re currently using albuterol several times a week for breakthrough symptoms, SMART therapy may be worth discussing with your doctor. It simplifies asthma management to a single inhaler and, based on clinical evidence, cuts exacerbation risk roughly in half compared to relying on albuterol alone. The key distinction is that Symbicort can function as a rescue inhaler only when prescribed that way, within a structured treatment plan, and only for asthma.